Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202104069 Randomized, double-blind, placebo-controlled, parallelgroup Phase 3 study to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/Itepekimab (anti-IL-33 mAb) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) TMUH Pulmonary Medicine/Sleep Clinic Pai-Chien Chou Yong-Ying
Zhang
0988128087
N202305114 A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Chronic obstructive pulmonary disease (COPD) TMUH Pulmonary Medicine/Sleep Clinic Pai-Chien Chou Yin-Ju Chen
0227372181 #7606
N202208038 A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab in Patients with Eosinophilic Chronic Rhinosinusitis with Nasal Polyps (ORCHID) Rhinosinusitis TMUH Pulmonary Medicine/Sleep Clinic Pai-Chien Chou Yin-Ju Chen
02-27372181 #7606
N202208040 A Phase 3, Multicenter, Randomized, Double-Blind Study of MK- 7684 with Pembrolizumab as a Coformulation (MK-7684A) Versus Pembrolizumab Monotherapy as First Line Treatment for Participants With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer Lung Cancer TMUH Pulmonary Medicine Chao-Hua Chiu Yi-Ting Lin
0960303216
N202209096 A PHASE II/III MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE TARGETED THERAPIES AS TREATMENTS FOR PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) HARBORING ACTIONABLE SOMATIC MUTATIONS DETECTED IN BLOOD (BFAST: BLOOD FIRST ASSAY SCREENING TRIAL) Lung Cancer TMUH Pulmonary Medicine Chao-Hua Chiu Yi-Ting Lin
0960303217
N202303062 A Phase 1b, Multicenter, 2-Part, Open-Label Study of Datopotamab Deruxtecan (Dato-DXd) in Combination with Immunotherapy with or without Carboplatin in Participants with Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION‑Lung04) Lung Cancer TMUH Pulmonary Medicine Chao-Hua Chiu Yi-Ting Lin
0960303218
N202307044 A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC) (eVOLVE-Lung02) Lung Cancer TMUH Pulmonary Medicine Chao-Hua Chiu Chen-Chun Chu
0933085872
N202309001 A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer Lung Cancer TMUH Pulmonary Medicine Chao-Hua Chiu Yi-Ting Lin
0960303216
N202311039 A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects with Non-Small Cell Lung Cancer – KisMET-01 Lung Cancer TMUH Pulmonary Medicine Chao-Hua Chiu Chen-Chun Chu
0933085872
N202211052 MASTER SCREENING STUDY TO DETERMINE BIOMARKER STATUS AND POTENTIAL TRIAL ELIGIBILITY FOR PATIENTS WITH MALIGNANT TUMORS Solid tumors TMUH Pulmonary Medicine Chao-Hua Chiu Chen-Chun Chu
0933085872
1 2 3 4 5 6 7 8 9 10 11 12 13 / 13

TOP